A detailed history of Eam Investors, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Eam Investors, LLC holds 578,613 shares of MNKD stock, worth $3.63 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
578,613
Holding current value
$3.63 Million
% of portfolio
0.63%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.01 - $6.7 $2.9 Million - $3.88 Million
578,613 New
578,613 $3.63 Million
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $1.32 Million - $2.34 Million
436,482 New
436,482 $2.3 Million
Q2 2022

Aug 12, 2022

BUY
$2.67 - $4.77 $663,967 - $1.19 Million
248,677 New
248,677 $947,000
Q2 2021

Aug 13, 2021

SELL
$3.61 - $5.45 $1.09 Million - $1.65 Million
-302,173 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$3.14 - $6.14 $618,429 - $1.21 Million
-196,952 Reduced 39.46%
302,173 $1.19 Million
Q4 2020

Feb 11, 2021

BUY
$1.79 - $4.04 $893,433 - $2.02 Million
499,125 New
499,125 $1.56 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.61B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.